The North America Interventional Oncology Market would witness market growth of 5.7% CAGR during the forecast period (2022-2028).
With advancements in technology, hybrid MRI and X-ray fluoroscopy systems (XMRI) might be employed to give precise needle placement for intervention as well as quick feedback on the tumor's reaction with sophisticated analysis. Early investigations have revealed that artificial intelligence and robotic technology have the potential to improve needle placement precision and reduce overall operation time. Improved 3D imaging & contrast agents, and also therapeutic ultrasound development, could lead to new breakthroughs in this imaging modality for IO.
Surgery, radiation, and chemotherapy are all cancer treatments with numerous adverse effects. Using interventional oncology, a catheter-based technique that provides treatment directly to the tumour, this is less of a concern. Patients with liver, colon, lung, kidney, bone/soft tissue, and metastatic tumours can benefit from interventional oncology, which is a minimally invasive treatment option. These image-guided methods could be used in place of or in tandem with other cancer treatments to give genuinely comprehensive care, instead of eliminating tumours via open surgical procedures.
In 2019, the total healthcare expenditure of the North America was 16.32 of the GDP. The market is growing due to reasons such as technological improvements and the affordability of minimally invasive techniques for the successful management of cancer in developed countries. One in every 16 people in the United States would be treated with lung cancer during their lifetime, as per the National Cancer Institute of the US Department of Health and Human Services. Lung cancer affects more than 228,000 people in the United States in 2018, with a positive diagnosis occurring every 2.3 minutes. As a result of this reason, the interventional oncology devices market in this region is growing.
Breast cancer would be detected in 26,900 Canadian women this year, with 5,000 deaths expected. Breast cancer is responsible for around 25% of new cancer diagnoses and 13% of all cancer deaths among Canadian women. Breast cancer would affect 1 in every 8 women at some point in their lives, and 1 in every 33 will die from it. Owing to this rise in number of cases, the demand for numerous treatments used for cancer would expand across the region in the coming years.
The US market dominated the North America Interventional Oncology Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $805.6 million by 2028. The Canada market is anticipated to grow at a CAGR of 4.6% during (2022 - 2028). Additionally, The Mexico market would showcase a CAGR of 7.4% during (2022 - 2028).
Based on Cancer Type, the market is segmented into Liver Cancer, Lung Cancer, Kidney Cancer, Breast Cancer, Prostate Cancer, Bone Metastasis, and Others. Based on Product Type, the market is segmented into Embolization Devices, Ablation Devices, and Support Devices. Based on End User, the market is segmented into Hospitals, Ambulatory Surgery Centers, and Research & Academic Institutes. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Global Interventional Oncology Market is Estimated to reach $2.9 Billion by 2028, at a CAGR of 6.2%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Boston Scientific Corporation, Teleflex, Inc., Cook Medical, Inc. (Cook Group), Medtronic PLC, Terumo Corporation , Johnson & Johnson (Johnson & Johnson Services, Inc.), Becton, Dickinson and Company, AngioDynamics, Inc., Merit Medical Systems, Inc., and HealthTronics, Inc. (Altaris Capital Partners, LLC)
Scope of the Study
Market Segments Covered in the Report:
By Cancer Type
- Liver Cancer
- Lung Cancer
- Kidney Cancer
- Breast Cancer
- Prostate Cancer
- Bone Metastasis
- Others
By Product Type
- Embolization Devices
- Ablation Devices
- Support Devices
By End User
- Hospitals
- Ambulatory Surgery Centers
- Research & Academic Institutes
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Boston Scientific Corporation
- Teleflex, Inc.
- Cook Medical, Inc. (Cook Group)
- Medtronic PLC
- Terumo Corporation
- Johnson & Johnson (Johnson & Johnson Services, Inc.)
- Becton, Dickinson and Company
- AngioDynamics, Inc.
- Merit Medical Systems, Inc.
- HealthTronics, Inc. (Altaris Capital Partners, LLC)
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Interventional Oncology Market, by Cancer Type
1.4.2 North America Interventional Oncology Market, by Product Type
1.4.3 North America Interventional Oncology Market, by End User
1.4.4 North America Interventional Oncology Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. North America Interventional Oncology Market by Cancer Type
3.1 North America Liver Cancer Market by Country
3.2 North America Lung Cancer Market by Country
3.3 North America Kidney Cancer Market by Country
3.4 North America Breast Cancer Market by Country
3.5 North America Prostate Cancer Market by Country
3.6 North America Bone Metastasis Market by Country
3.7 North America Others Market by Country
Chapter 4. North America Interventional Oncology Market by Product Type
4.1 North America Embolization Devices Market by Country
4.2 North America Ablation Devices Market by Country
4.3 North America Support Devices Market by Country
Chapter 5. North America Interventional Oncology Market by End User
5.1 North America Hospitals Market by Country
5.2 North America Ambulatory Surgery Centers Market by Country
5.3 North America Research & Academic Institutes Market by Country
Chapter 6. North America Interventional Oncology Market by Country
6.1 US Interventional Oncology Market
6.1.1 US Interventional Oncology Market by Cancer Type
6.1.2 US Interventional Oncology Market by Product Type
6.1.3 US Interventional Oncology Market by End User
6.2 Canada Interventional Oncology Market
6.2.1 Canada Interventional Oncology Market by Cancer Type
6.2.2 Canada Interventional Oncology Market by Product Type
6.2.3 Canada Interventional Oncology Market by End User
6.3 Mexico Interventional Oncology Market
6.3.1 Mexico Interventional Oncology Market by Cancer Type
6.3.2 Mexico Interventional Oncology Market by Product Type
6.3.3 Mexico Interventional Oncology Market by End User
6.4 Rest of North America Interventional Oncology Market
6.4.1 Rest of North America Interventional Oncology Market by Cancer Type
6.4.2 Rest of North America Interventional Oncology Market by Product Type
6.4.3 Rest of North America Interventional Oncology Market by End User
Chapter 7. Company Profiles
7.1 Boston Scientific Corporation
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 SWOT Analysis
7.2 Teleflex, Inc.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.3 Cook Medical, Inc. (Cook Group)
7.3.1 Company Overview
7.4 Medtronic PLC
7.4.1 Company overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expenses
7.4.5 Recent Strategies and Developments
7.4.5.1 Product Launches and Product Expansions:
7.4.6 SWOT Analysis
7.5 Terumo Corporation
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Regional Analysis
7.5.5 Recent Strategies and Developments
7.5.5.1 Partnerships, Collaborations and Agreements:
7.5.5.2 Acquisitions and Mergers:
7.6 Johnson & Johnson (Johnson & Johnson Services, Inc.)
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental &Regional Analysis
7.6.4 Research & Development Expenses
7.6.5 SWOT Analysis
7.7 Becton, Dickinson and Company
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expense
7.7.5 SWOT Analysis
7.8 AngioDynamics, Inc.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Regional Analysis
7.8.4 Research & Development Expenses
7.9 Merit Medical Systems, Inc.
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental and Regional Analysis
7.9.4 Research & Development Expenses
7.10. HealthTronics, Inc. (Altaris Capital Partners, LLC)
7.10.1 Company Overview
TABLE 1 North America Interventional Oncology Market, 2018 - 2021, USD Million
TABLE 2 North America Interventional Oncology Market, 2022 - 2028, USD Million
TABLE 3 North America Interventional Oncology Market by Cancer Type, 2018 - 2021, USD Million
TABLE 4 North America Interventional Oncology Market by Cancer Type, 2022 - 2028, USD Million
TABLE 5 North America Liver Cancer Market by Country, 2018 - 2021, USD Million
TABLE 6 North America Liver Cancer Market by Country, 2022 - 2028, USD Million
TABLE 7 North America Lung Cancer Market by Country, 2018 - 2021, USD Million
TABLE 8 North America Lung Cancer Market by Country, 2022 - 2028, USD Million
TABLE 9 North America Kidney Cancer Market by Country, 2018 - 2021, USD Million
TABLE 10 North America Kidney Cancer Market by Country, 2022 - 2028, USD Million
TABLE 11 North America Breast Cancer Market by Country, 2018 - 2021, USD Million
TABLE 12 North America Breast Cancer Market by Country, 2022 - 2028, USD Million
TABLE 13 North America Prostate Cancer Market by Country, 2018 - 2021, USD Million
TABLE 14 North America Prostate Cancer Market by Country, 2022 - 2028, USD Million
TABLE 15 North America Bone Metastasis Market by Country, 2018 - 2021, USD Million
TABLE 16 North America Bone Metastasis Market by Country, 2022 - 2028, USD Million
TABLE 17 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 18 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 19 North America Interventional Oncology Market by Product Type, 2018 - 2021, USD Million
TABLE 20 North America Interventional Oncology Market by Product Type, 2022 - 2028, USD Million
TABLE 21 North America Embolization Devices Market by Country, 2018 - 2021, USD Million
TABLE 22 North America Embolization Devices Market by Country, 2022 - 2028, USD Million
TABLE 23 North America Ablation Devices Market by Country, 2018 - 2021, USD Million
TABLE 24 North America Ablation Devices Market by Country, 2022 - 2028, USD Million
TABLE 25 North America Support Devices Market by Country, 2018 - 2021, USD Million
TABLE 26 North America Support Devices Market by Country, 2022 - 2028, USD Million
TABLE 27 North America Interventional Oncology Market by End User, 2018 - 2021, USD Million
TABLE 28 North America Interventional Oncology Market by End User, 2022 - 2028, USD Million
TABLE 29 North America Hospitals Market by Country, 2018 - 2021, USD Million
TABLE 30 North America Hospitals Market by Country, 2022 - 2028, USD Million
TABLE 31 North America Ambulatory Surgery Centers Market by Country, 2018 - 2021, USD Million
TABLE 32 North America Ambulatory Surgery Centers Market by Country, 2022 - 2028, USD Million
TABLE 33 North America Research & Academic Institutes Market by Country, 2018 - 2021, USD Million
TABLE 34 North America Research & Academic Institutes Market by Country, 2022 - 2028, USD Million
TABLE 35 North America Interventional Oncology Market by Country, 2018 - 2021, USD Million
TABLE 36 North America Interventional Oncology Market by Country, 2022 - 2028, USD Million
TABLE 37 US Interventional Oncology Market, 2018 - 2021, USD Million
TABLE 38 US Interventional Oncology Market, 2022 - 2028, USD Million
TABLE 39 US Interventional Oncology Market by Cancer Type, 2018 - 2021, USD Million
TABLE 40 US Interventional Oncology Market by Cancer Type, 2022 - 2028, USD Million
TABLE 41 US Interventional Oncology Market by Product Type, 2018 - 2021, USD Million
TABLE 42 US Interventional Oncology Market by Product Type, 2022 - 2028, USD Million
TABLE 43 US Interventional Oncology Market by End User, 2018 - 2021, USD Million
TABLE 44 US Interventional Oncology Market by End User, 2022 - 2028, USD Million
TABLE 45 Canada Interventional Oncology Market, 2018 - 2021, USD Million
TABLE 46 Canada Interventional Oncology Market, 2022 - 2028, USD Million
TABLE 47 Canada Interventional Oncology Market by Cancer Type, 2018 - 2021, USD Million
TABLE 48 Canada Interventional Oncology Market by Cancer Type, 2022 - 2028, USD Million
TABLE 49 Canada Interventional Oncology Market by Product Type, 2018 - 2021, USD Million
TABLE 50 Canada Interventional Oncology Market by Product Type, 2022 - 2028, USD Million
TABLE 51 Canada Interventional Oncology Market by End User, 2018 - 2021, USD Million
TABLE 52 Canada Interventional Oncology Market by End User, 2022 - 2028, USD Million
TABLE 53 Mexico Interventional Oncology Market, 2018 - 2021, USD Million
TABLE 54 Mexico Interventional Oncology Market, 2022 - 2028, USD Million
TABLE 55 Mexico Interventional Oncology Market by Cancer Type, 2018 - 2021, USD Million
TABLE 56 Mexico Interventional Oncology Market by Cancer Type, 2022 - 2028, USD Million
TABLE 57 Mexico Interventional Oncology Market by Product Type, 2018 - 2021, USD Million
TABLE 58 Mexico Interventional Oncology Market by Product Type, 2022 - 2028, USD Million
TABLE 59 Mexico Interventional Oncology Market by End User, 2018 - 2021, USD Million
TABLE 60 Mexico Interventional Oncology Market by End User, 2022 - 2028, USD Million
TABLE 61 Rest of North America Interventional Oncology Market, 2018 - 2021, USD Million
TABLE 62 Rest of North America Interventional Oncology Market, 2022 - 2028, USD Million
TABLE 63 Rest of North America Interventional Oncology Market by Cancer Type, 2018 - 2021, USD Million
TABLE 64 Rest of North America Interventional Oncology Market by Cancer Type, 2022 - 2028, USD Million
TABLE 65 Rest of North America Interventional Oncology Market by Product Type, 2018 - 2021, USD Million
TABLE 66 Rest of North America Interventional Oncology Market by Product Type, 2022 - 2028, USD Million
TABLE 67 Rest of North America Interventional Oncology Market by End User, 2018 - 2021, USD Million
TABLE 68 Rest of North America Interventional Oncology Market by End User, 2022 - 2028, USD Million
TABLE 69 key Information – Boston Scientific Corporation
TABLE 70 key Information – Teleflex, Inc.
TABLE 71 key Information – Cook Medical, Inc.
TABLE 72 Key Information – Medtronic PLC
TABLE 73 Key Information – Terumo Corporation
TABLE 74 Key information – Johnson & Johnson
TABLE 75 Key information – Becton, Dickinson and Company
TABLE 76 Key Information – AngioDynamics, Inc.
TABLE 77 Key Information – Merit Medical Systems, Inc.
TABLE 78 Key Information – HealthTronics, Inc.
List of Figures
FIG 1 Methodology for the research
FIG 2 SWOT Analysis: Boston Scientific Corporation
FIG 3 Swot analysis: Medtronic plc
FIG 4 SWOT analysis: Johnson & Johnson
FIG 5 Swot analysis: Becton, Dickinson and company